Beta Estimation with Stock Return Outliers: The Case of U.S. Pharmaceutical Companies
34 Pages Posted: 29 May 2009 Last revised: 8 Jun 2009
Date Written: May 20, 2009
Abstract
Efficient estimation of the equity cost of public corporations is an essential component of computing the required rate of return of real investment projects, and therefore the basis for a rational investment policy. The accepted methodology relies on the CAPM model to define the return risk premium, and the OLS method to estimate the beta risk coefficient required for calculating the premium. This study challenges the use of the OLS method for this task by demonstrating its vulnerability to the impact of stock return outliers caused by large, unpredictable, company-specific events. That impact is verified on a sample of U.S. pharmaceutical companies by comparing the OLS estimation performance with that of our proposed method based on Huber’s Robust M (HRM) estimator, a related statistical method that follows a mixed return model identifying regular and outlier return components. Using the HRM-estimated beta as a benchmark, we demonstrate that (1) outliers can substantially bias the OLS beta, (2) the bias is negatively correlated with company size, and (3) the size of the bias is often moderated but not eliminated by extending the estimation period. The latter finding suggests that a robust method like HRM is preferable where estimators ought to represent the behavior of the majority of historical data despite the presence of outliers. The risk of trusting the OLS beta is especially high when estimation must rely on a small sample.
Keywords: stock beta estimation, OLS vs. Robust M beta estimation, equity cost of capital, pharmaceutical industry
JEL Classification: G12, G31
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
What Do We Know About Capital Structure? Some Evidence from International Data
By Raghuram G. Rajan and Luigi Zingales
-
The Theory and Practice of Corporate Finance: Evidence from the Field
By John R. Graham and Campbell R. Harvey
-
The Theory and Practice of Corporate Finance: The Data
By John R. Graham and Campbell R. Harvey
-
Market Timing and Capital Structure
By Malcolm P. Baker and Jeffrey Wurgler
-
Market Timing and Capital Structure
By Malcolm P. Baker and Jeffrey Wurgler
-
Testing Tradeoff and Pecking Order Predictions About Dividends and Debt
By Eugene F. Fama and Kenneth R. French
-
Testing Static Trade-Off Against Pecking Order Models of Capital Structure
-
Optimal Capital Structure Under Corporate and Personal Taxation
By Harry Deangelo and Ronald W. Masulis